The current proposal is a competitive renewal which seeks continued support for ongoing studies which in the past 22 years have dealt with the physicochemical, immunologic and biosynthetic aspects of basement membrane macromolecules. The proposed studies will focus on structure-function relationships at the molecular level of two basement membrane macromolecules, namely, type IV collagen and laminin. Although, the ultrastructure of the type IV molecule has been well described, our knowledge of the macromolecular organization of basement membranes remains incomplete.
Aim 1 will be an attempt to continue our studies of the ultrastructure of anterior lens capsule (ALC) using extraction pro- cedures that will yield molecules in different states of aggregation. In recent years we learned a great deal about the antigenic epitopes on basement membrane macromolecules that give rise to nephritogenic antibodies. Both the NC-1 and 7-S domains have amino acid sequences which react specifically with sera from patients with Goodpasture syndrome (GP) and post-streptococcal glomerulonephritis (APSGN).
Aim 2 will be an attempt to determine the immunologic reactivity of synthetic peptides selected from specific peptide regions of the NC-1 and 7-S domains of type IV collagen chains. Our approach will involve the selection of antigenic regions from the newly described alpha chains by use of predictive programs for secondary structure and determination of immunoreactivity of the synthetic peptides with antisera to NC-1 and 7-S domains as well as sera from patients with a variety of immune mediated renal diseases. The binding of type IV collagen to cells and to other constituents of basement membranes allows for the normal organization of these structures and provides a mechanically stable support for cells in the basement membrane zone.
Aim 3 will involve the study of the role of type IV collagen and its domains in cell adhesion and migration as well as their effect on neutrophil binding and activation. The discovery of laminin isoforms in normal tissues and their absence in solid tumors provides an opportunity to study structure-function relationships of specific laminin subunits.
In Aim 4 we will study laminin gene expression and its regulation in normal and neoplastic cell lines and tissues and compare the biological activity of laminins synthesized by such cells and tissues.

Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
1996
Total Cost
Indirect Cost
Myers, Jeanne C; Amenta, Peter S; Dion, Arnold S et al. (2007) The molecular structure of human tissue type XV presents a unique conformation among the collagens. Biochem J 404:535-44
Shahan, Tracy; Grant, Derrick; Tootell, Mason et al. (2004) Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis. Connect Tissue Res 45:151-63
Myers, Jeanne C; Li, Deqin; Amenta, Peter S et al. (2003) Type XIX collagen purified from human umbilical cord is characterized by multiple sharp kinks delineating collagenous subdomains and by intermolecular aggregates via globular, disulfide-linked, and heparin-binding amino termini. J Biol Chem 278:32047-57
Fawzi, A; Robinet, A; Monboisse, J C et al. (2000) A peptide of the alpha 3(IV) chain of type IV collagen modulates stimulated neutrophil function via activation of cAMP-dependent protein kinase and Ser/Thr protein phosphatase. Cell Signal 12:327-35
Shahan, T A; Fawzi, A; Bellon, G et al. (2000) Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3). J Biol Chem 275:4796-802
Pasco, S; Han, J; Gillery, P et al. (2000) A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res 60:467-73
Shahan, T A; Ohno, N; Pasco, S et al. (1999) Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP. Connect Tissue Res 40:221-32
Shahan, T A; Ziaie, Z; Pasco, S et al. (1999) Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res 59:4584-90
Han, J; Jenq, W; Kefalides, N A (1999) Integrin alpha2beta1 recognizes laminin-2 and induces C-erb B2 tyrosine phosphorylation in metastatic human melanoma cells. Connect Tissue Res 40:283-93
Zhang, Y; Niu, Z; Cohen, A J et al. (1999) The internal chondrocyte-specific promoter of the chick type III collagen gene is activated by AP1 and is repressed in fibroblasts by a complex containing an LBP1-related protein. Nucleic Acids Res 27:4090-9

Showing the most recent 10 out of 93 publications